ArticleFrontiers in oncology2025

IL-18-primed NK cells recruit dendritic cells and potentiate tumor therapy mediated by PD-1 blockade.

Yoshiya Ohno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.